CellSeed Inc logo

7776 - CellSeed Inc News Story

¥256 -3.0  -1.2%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.8m
Revenue £1.05m
Position in Universe 3274th / 3891

TABLE-CellSeed -2017 group results

Wed 14th February, 2018 7:00am
Feb 14 (Reuters)-  
          CellSeed Inc.  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended       Year ended       Year to        NEXT      
              Dec 31, 2017     Dec 31, 2016   Dec 31, 2018      YEAR        
                 LATEST          YEAR-AGO        COMPANY        COMPANY     
                 RESULTS         RESULTS        FORECAST      H1 FORECAST   
  Sales          85 mln          100 mln          1.17          300 mln     
               (-15.5 pct)     (-47.8 pct)                                  
  Operating     loss 1.02       loss 1.41        20 mln      loss 300 mln   
  Recurring   loss 964 mln      loss 1.42        50 mln      loss 280 mln   
  Net 
  Net         loss 966 mln      loss 1.41        40 mln      loss 280 mln   
  EPS        loss 93.29 yen  loss 154.94 yen    3.50 yen    loss 24.50 yen  
  Ann Div          NIL             NIL             NIL                      
  -Q2 Div          NIL             NIL             NIL                      
  -Q4 Div          NIL             NIL             NIL                      
   
  NOTE - CellSeed Inc.. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7776.T 
  ((Tokyo Headline News Desk +813 6441 1812))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.